Cargando…
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
SIMPLE SUMMARY: Loss of SMARCB1 has been identified as the sole mutation in a number of rare pediatric and adult cancers, most of which have a poor prognosis despite intensive therapies including surgery, radiation, and chemotherapy. Thus, a more robust understanding of the mechanisms driving this s...
Autores principales: | Cooper, Garrett W., Hong, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332782/ https://www.ncbi.nlm.nih.gov/pubmed/35892904 http://dx.doi.org/10.3390/cancers14153645 |
Ejemplares similares
-
SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma: A Novel Member of the Expanding Family of SMARCB1-deficient Neoplasms
por: Agaimy, Abbas, et al.
Publicado: (2014) -
SMARCB1/INI1-deficient tumors of adulthood
por: Parker, Nathaniel A., et al.
Publicado: (2020) -
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms
por: Haberecker, Martina, et al.
Publicado: (2022) -
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments
por: Ngo, Carine, et al.
Publicado: (2022) -
Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)